Jiangbo Pharma Q1 revenues up 13.5%
Jiangbo Pharma has posted a net income of $10.57m for the first quarter 2010, or $0.29 per diluted share, compared to net income of $1.97m, or $1.68 loss
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.